HCM
DXCM icon

Highbridge Capital Management’s DexCom DXCM Stock Holding History

Highbridge Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-443,312
Closed -$10.5M – 581
2018
Q2 		$10.5M Buy
+443,312
New +$9.4M 0.21% 122
2017
Q1 		– Sell
-199,900
Closed -$3.9M – 1487
2016
Q4 		$2.98M Buy
+199,900
New +$3.54M 0.05% 314

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Highbridge Capital Management's DXCM Position: Q3 2018 in Review

Highbridge Capital Management sold out of DexCom (DXCM) in Q3 2018, closing a stake of 443,312 shares — an estimated $10.5M sold.

Highbridge Capital Management first reported a position in DXCM in Q4 2016 and held it in 2 quarters. The position peaked at $10.5M in Q2 2018. 364 funds tracked by Wall St. Rank hold DXCM as of Q3 2018.

  • Highbridge Capital Management reported no remaining DexCom position as of Q3 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 443,312 DexCom shares in Q3 2018, an estimated $10.5M.
  • Highbridge Capital Management first reported a position in DexCom in Q4 2016 and held it in 2 quarters.
  • Highbridge Capital Management's DexCom position peaked at $10.5M in Q2 2018.
  • 364 funds tracked by Wall St. Rank held DexCom as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.